Section Arrow
Quote
EVO.NASDAQ
- Evotec SE
Quotes are at least 15-min delayed:2026/05/13 07:33 EDT
Pre Market
Last
 2.69
-0.31 (-10.33%)
Bid
2.66
Ask
2.69
High 2.92 
Low 2.68 
Volume 53.44K 
Regular Hours (Closed)
Last
 3
-0.06 (-1.96%)
Day High 
3.045 
Prev. Close
3.06 
1-M High
3.41 
Volume 
115.84K 
Bid
2.66
Ask
2.69
Day Low
2.94 
Open
3.02 
1-M Low
2.69 
Market Cap 
1.09B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.09 
20-SMA 3.14 
50-SMA 2.84 
52-W High 4.8 
52-W Low 2.308 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.55/0.09
Enterprise Value
1.43B
Balance Sheet
Book Value Per Share
2.31
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
788.37M
Operating Revenue Per Share
2.45
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health25.03-4.11-14.10%57.14PE
Pre Market 24.85 -0.18 -0.72%
ZTSZOETIS76.94+0.27+0.35%12.61PE
Pre Market 77.1 +0.16 +0.21%
CPHIChina Pharma Holdings Inc0.8927+0.35855+67.13%-- 
Pre Market 0.8443 -0.0484 -5.42%
VTRSViatris17.17+0.25+1.48%-- 
Pre Market 17.13 -0.04 -0.23%
ELANElanco Animal Health21.43-0.29-1.34%-- 
Pre Market 22.9 +1.47 +6.86%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.